Mayne Pharma Group Ltd (MYX) has signed a 20-year exclusive supply and license agreement with Mithra Pharmaceuticals SA to commercialise a novel oral contraceptive comprising Estetrol (E4), and drospirenone (E4/DRSP) in the United States
http://crweworld.com/article/news-provided-by-pr-newswire/1259493/mayne-pharma-signs-20-year-exclusive-license-and-supply-agreement-for-novel-oral-contraceptive-in-the-us
Mayne Pharma Group Ltd (MYX) has signed a 20-year exclusive...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.25 |
Change
0.000(0.00%) |
Mkt cap ! $531.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27 | $6.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.26 | 250 | 1 |
View Market Depth
| Last trade - 09.42am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.16 |
Change
0.000 ( 1.34 %) |
||||
| Open | High | Low | Volume | ||
| $6.16 | $6.16 | $6.15 | 1013 | ||
| Last updated 10.07am 17/05/2024 ? | |||||
| MYX (ASX) Chart |
Day chart unavailable